Mutation Analysis of Isocitrate Dehydrogenase in Acute Lymphoblastic Leukemia

Genetic Testing and Molecular Biomarkers - United States
doi 10.1089/gtmb.2011.0323
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Mary Ann Liebert Inc

Related search

FDA Approval Summary: Ivosidenib for Relapsed or Refractory Acute Myeloid Leukemia With an Isocitrate Dehydrogenase-1 Mutation

Clinical Cancer Research
Cancer ResearchOncology
2019English

Collagen XVIII Mutation in Knobloch Syndrome With Acute Lymphoblastic Leukemia

American Journal of Medical Genetics, Part A
Genetics
2010English

Mutation of Isocitrate Dehydrogenase 1 in Cholangiocarcinoma Impairs Tumor Progression by Inhibiting Isocitrate Metabolism

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2020English

Acute Lymphoblastic Leukemia

2016English

Acute Lymphoblastic Leukemia

2020English

Acute Lymphoblastic Leukemia

English

Acute Lymphoblastic Leukemia

2009English

Acute Lymphoblastic Leukemia

2019English

Blinatumomab in Acute Lymphoblastic Leukemia

Expert Review of Anticancer Therapy
OncologyPharmacology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy